Janney Montgomery Scott LLC grew its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 9.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,163 shares of the company’s stock after acquiring an additional 2,668 shares during the quarter. Janney Montgomery Scott LLC’s holdings in BlackRock Health Sciences Term Trust were worth $449,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of BMEZ. Saba Capital Management L.P. raised its holdings in BlackRock Health Sciences Term Trust by 0.4% in the 4th quarter. Saba Capital Management L.P. now owns 20,750,913 shares of the company’s stock worth $298,813,000 after acquiring an additional 89,523 shares during the last quarter. Sit Investment Associates Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 7.9% in the 4th quarter. Sit Investment Associates Inc. now owns 1,724,706 shares of the company’s stock worth $24,836,000 after purchasing an additional 125,599 shares in the last quarter. Invesco Ltd. raised its stake in shares of BlackRock Health Sciences Term Trust by 0.8% in the fourth quarter. Invesco Ltd. now owns 1,543,745 shares of the company’s stock worth $22,230,000 after purchasing an additional 11,684 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of BlackRock Health Sciences Term Trust by 10.9% during the fourth quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock valued at $19,517,000 after purchasing an additional 132,926 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at $10,869,000.
BlackRock Health Sciences Term Trust Trading Down 0.1%
NYSE BMEZ opened at $14.46 on Friday. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75. The stock has a 50-day moving average of $14.43 and a 200 day moving average of $14.90.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- What is the Euro STOXX 50 Index?
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.